Mediterranean Diet Tied to Fewer Adverse Pregnancy Outcomes

THURSDAY, Dec. 29, 2022 (HealthDay News) -- Adherence to a Mediterranean diet is associated with a lower risk for adverse pregnancy outcomes (APOs), according to a study published online Dec. 22 in JAMA Network Open.
Nour Makarem, Ph.D., from Columbia University in New York City, and colleagues assessed whether adherence to a Mediterranean diet pattern around the time of conception is associated with a lower risk for developing any APO. The analysis included 7,798 racially, ethnically, and geographically diverse women with singleton pregnancies who had complete diet data.
The researchers found that the prevalence of high, moderate, and low concordance to a Mediterranean diet pattern around the time of conception was 30.6, 31.2, and 38.2 percent, respectively. A high versus a low Alternate Mediterranean Diet score was associated with lower odds of any APO (adjusted odds ratio [aOR], 0.79), as well as, specifically, lower odds of preeclampsia or eclampsia (aOR, 0.72) and gestational diabetes (aOR, 0.63). Findings were similar by race, ethnicity, and prepregnancy body mass index. However, associations were stronger among women aged 35 years or older (aOR, 0.54).
"Intervention studies are needed to assess whether dietary modification around the time of conception can reduce risk of APOs and their downstream associations with future development of cardiovascular disease risk factors and overt disease," the authors write.
Two authors disclosed financial ties to the pharmaceutical industry.
Related Posts
Infectious Diseases Society of America, Sept. 29-Oct. 3
The annual meeting of the Infectious Diseases Society of America was held...
Biden aprueba una ley que prohíbe unos productos para dormir vinculados con muertes infantiles
MARTES, 17 de mayo de 2022 (HealthDay News) -- Una nueva ley aprobada por el...
Amazon probará drones para entregar medicamentos a tu puerta
VIERNES, 20 de Octubre de 2023 (HealthDay News) -- Pronto, podrías salir a la...
Clinical Guideline Developed for Use of Biomarkers in Ulcerative Colitis
FRIDAY, March 17, 2023 (HealthDay News) -- In a clinical practice guideline...